undamentalytics Newsletter
Sign in

Nephros Inc income statement

In fiscal 2025, Nephros Inc reported revenue of $18.8m, up 32.7% on the year before, operating income of $1.1m (a 6.1% margin) and net income of $1.2m, or $0.11 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue322222246109101014141921
Cost of revenue———————2244556578
Gross profit1111111236565891213
Research and development00111111233111111
Selling, general and administrative33433333566789899
Operating income−2−2−3−3−3−3−3−2−3−3−4−3−4−2012
Interest expense0000000000000000—
Income before tax——————−3−3−3−3−5——−201—
Income tax———————−2−0−0—000000
Net income4−7−71−7−3−3−1−3−3−5−4−7−2012
Diluted EPS$4.18−$7.29−$0.59−$1.62−$2.79−$0.09−$0.06−$0.02−$0.50−$0.45−$0.52−$0.41−$0.73−$0.15$0.01$0.11$0.16
Diluted shares (average)——1m2m3m4m5m6m7m8m9m10m10m10m11m11m11m
EBITDA−2−2−3−3−3−3−3−2−3−3−4−3−4−1012

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: NEPH vs ZJYLNEPH vs VVOSNEPH vs SNOABDMD vs NEPH

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Nephros Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nephros Inc.